Jonathan D. Nahas, MD

faculty photo
Assistant Professor of Clinical Medicine (Gastroenterology)
Advanced Medicine Clinical Effectiveness Team member, HUP
Director of Inpatient Hepatology, HUP
Lead Physician, Ravdin 9, HUP
Co-Director of ILEARN multidisciplinary ALD/AUD clinic, HUP
Department: Medicine

Contact information
Hospital of the University of Pennsylvania
3400 Spruce Street
2 Dulles
Penn Transplant Institute
Philadelphia, PA 19104
Education:
BA (Economics, minor in Political Science)
University of Miami, 2009.
MD (Doctor of Medicine)
University of Miami Miller School of Medicine, 2014.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Goyal T, Kaplan D, Nahas J: Terlipressin Use Leads to a Significantly Reduced Creatinine Among hospitalized patients with Hepatorenal Syndrome when Compared with Midodrine/Octreotide in a Real-World Experience. AASLD Annual Meeting, Washington, DC Nov 2025 Notes: Poster presentation.

Nahas J, Accime B, Bittermann T, Cerra C, Goswami Banerjee A, Johnson K, Maggiaro R, Patrick E, Weinberg E, Weinrieb R, Serper M: A Blueprint for Multidisciplinary Care for Alcohol-Associated Liver Disease Across Transplant Pathway: Structure, MAUD Utilization, and Early Outcomes. AASLD Annual Meeting, Washington, DC Nov 2025 Notes: Oral presentation.

Seija L, Keddem S, Schachter A, Ahluwalia V, Guevara J, Nahas J, Serper M, Schapira M, Klaiman T, Weinberg E, Weinrieb R, Goswami Banerjee A, Bittermann T: Integrated Liver Transplant Engagement & Recovery Network: A Person-Centered Approach to Alcohol-Associated Liver Disease. AASLD Annual Meeting, Washington, DC Nov 2025 Notes: Poster presentation.

Vadaketh J, Saqlain J, Panchal S, Nahas J, Mitchell O: Experience and Confidence of Gastroenterology Faculty and Fellows in Placement of Balloon Tamponade Devices in Acute Variceal Hemorrhage. AASLD Annual Meeting, Washington, DC Nov 2025 Notes: Poster presentation.

Goyal T, Khanna T, Kaplan D, Nahas J: Terlipressin Is Associated With Decreased Renal Replacement Therapy Compared With Midodrine/Octreotide Among Patients With Hepatorenal Syndrome. ACG Annual Meeting, Phoenix, AZ Oct 2025 Notes: Poster presentation.

Nahas J: Alcohol-Associated Liver Diseases Diagnosis and Management. Penn Medicine Physician Interviews podcast Feb 2025.

DeSousa A, Goyal T, Kaplan D, Nahas J : Terlipressin Is Associated with Decreased Healthcare Resource Utilization Compared with Midodrine/Octreotide Among Patients with Hepatorenal Syndrome. AASLD Annual Meeting, San Diego, CA Nov 2024 Notes: Poster presentation.

Goswami A, Weinberg E, Coraluzzi E, Bittermann T, Nahas J, Addis S, Weinrieb R, Serper M: A Tailored Virtual Program for Alcohol Use Disorder Treatment Among Liver Transplant Candidates and Recipients Is Feasible and Associated With Lower Post-Transplant Relapse. Clinical Transplantation 38(7), July 2024.

Weinberg EM, Goswami Banerjee A, Bittermann T, Nahas J, Coraluzzi L, Addis S, Weinrieb R, Serper M: Total Recovery-LT: A Novel Program for Alcohol Use Disorder Treatment among Liver Transplant Candidates and Recipients. American Transplant Congress Annual Meeting, Philadelphia, PA June 2024 Notes: Oral presentation.

Winters AC, Nathani RR, Bowman CA, Nahas J, Schiano TD, Florman SS, Im GY: Universal alcohol biomarker monitoring improves drinking detection and accountability during evaluation for liver transplantation. Liver Transplantation 30(3): 331-333, Mar 2024.

back to top
Last updated: 11/18/2025
The Trustees of the University of Pennsylvania